secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2026-08-06T10:04:34+00:00
Accession:  0001295947-26-000040
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Q1 revenue $265.7M (+6.5%), adj. EPS $0.98; raises FY outlook to $1.29-1.315B
--------------------------------------------------------------------------------

- Q1 revenue $265.7M (+6.5% YoY); organic sales growth 3.2% exceeded expectations.
- GAAP diluted EPS $0.61; adjusted diluted EPS $0.98 vs $0.95 prior year.
- Closed Breathe Right acquisition (June) and LaCorium (July); added $6M revenue in Q1.
- Raised FY2027 outlook: revenue $1,290-$1,315M, adj. EPS $4.55-$4.65 (from $4.42-$4.51).
- Issued $400M 6.25% senior notes due 2034, extending nearest maturity to 2031.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000040/0001295947-26-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000040/pbh-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001295947-26-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer